SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-129695
Filing Date
2013-03-27
Accepted
2013-03-27 17:22:31
Documents
6
Period of Report
2012-11-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d511161d8k.htm 8-K 19279
2 EX-99.1 d511161dex991.htm EX-99.1 83227
3 EX-99.2 d511161dex992.htm EX-99.2 491300
4 GRAPHIC g511161side1.jpg GRAPHIC 7945
5 GRAPHIC g511161side2.jpg GRAPHIC 816
6 GRAPHIC g511161side27.jpg GRAPHIC 7719
  Complete submission text file 0001193125-13-129695.txt   618050
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 13720823
SIC: 2834 Pharmaceutical Preparations